Follow on Google News News By Tag * Takeda * 2003-15 * Pharmaceutical * Prescription * Geography * Consensus * Pharmavitae * 2003-09 * Molecule * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | New Market Research Report: Takeda Pharmaceutical Co., Ltd: PharmaVitae ProfileFast Market Research recommends "Takeda Pharmaceutical Co., Ltd: PharmaVitae Profile" from Datamonitor, now available
Features and benefits Gain insight into Takeda's strategic outlook across the next 6 years Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source. Highlights Strategic insight into the prospects for Takeda over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales. Your key questions answered Benchmark Takeda's performance against key rivals in the prescription pharmaceutical sector Discover if Takeda will overcome generic competition facing its biggest selling medications Investigate the diverse strategies being employed by Japan's oldest and largest pharmaceutical player For more information or to purchase this report, go to: - http://www.fastmr.com/ Partial Table of Contents: TABLE OF CONTENTS ABOUT DATAMONITOR HEALTHCARE 2 About the PharmaVitae team 2 Chapter 1 About this profile 3 PharmaVitae Explorer database 3 Chapter structure 3 Data sourcing 4 Chapter 2 Executive summary 5 Key findings 5 Prescription pharmaceutical sales and growth rate performance, 2003-15 6 Financial performance, 2003-15 8 Takeda: PharmaVitae forecasts at a glance 9 Strategic insight 10 SWOT analysis 15 Chapter 3 Quarterly news update 22 Latest prescription pharma product news 22 Latest corporate news 25 Future product milestones 27 Chapter 4 Company introduction 28 Key findings 28 Background 29 Key corporate developments 29 M&A history 31 Chapter 5 Company sales 33 Key findings 33 Prescription pharmaceutical sales and growth rate analysis, 2003-15 34 Product analysis 36 Therapy area analysis 42 Geographic analysis 44 Launch/core/ Molecule type analysis 51 Externalization analysis 53 Chapter 6 Company financials 55 Key findings 55 Reconciliation between PharmaVitae- Operating costs and profit analysis 57 Chapter 7 Key products 62 Overview 62 Chapter 8 Appendix 93 References 93 Abbreviations 93 Exchange rates 95 About Datamonitor 96 Datamonitor consulting 96 Disclaimer 98 TABLE OF TABLES Table 1: Takeda - PharmaVitae forecasts at a glance 9 Table 2: Takeda future product milestones, 2010-12 27 Table 3: Takeda product portfolio overview ($m), 2003-09 37 Table 4: Takeda product portfolio overview ($m), 2009-15 39 Table 5: Takeda prescription pharmaceutical sales by therapy area ($m), 2009-15 43 Table 6: Takeda prescription pharmaceutical sales by geographic region ($m), 2009-15 45 Table 7: Takeda launch portfolio overview ($m), 2009-15 47 Table 8: Takeda core portfolio overview ($m), 2009-15 48 Table 9: Takeda expiry portfolio overview ($m), 2009-15 49 Table 10: Takeda prescription pharmaceutical sales by molecule type ($m), 2009-15 52 Table 11: Takeda prescription pharmaceutical sales by source ($m), 2009-15 54 Table 12: Total Takeda sales by business unit ($m), 2003-09 56 Table 13: Takeda operating revenue/cost analysis ($m), 2003-09 58 Table 14: Takeda operating cost ratio analysis (% of total revenues), 2003-09 59 Table 15: Takeda operating cost ratio analysis (% of total revenues), 2009-15 60 Table 16: Takeda operating revenue/cost analysis ($m), 2009-15 61 Table 17: Takeda Key products overview 62 Table 18: Dexilant: overview 64 Table 19: Dexilant: sales forecast ($m), 2009-15 65 Table 20: Blopress: overview 67 Table 21: Blopress comp: overview 68 Table 22: Blopress: sales forecast ($m), 2009-15 69 Table 23: Blopress comp: sales forecast ($m), 2009-15 69 Table 24: Actos: overview 72 Table 25: ACTOplus met: overview 73 Table 26: Actos: sales forecast ($m), 2009-15 74 Table 27: ACTOplus met: sales forecast ($m), 2009-15 74 Table 28: Lupron Depot: overview 77 Table 29: Lupron Depot: sales forecast ($m), 2009-15 78 Table 30: Velcade: overview 80 Table 31: Velcade: sales forecast ($m), 2009-15 81 Table 32: Alogliptin: overview 83 Table 33: Alogliptin/ACTOS combo: overview 84 Table 34: Alogliptin: sales forecast ($m), 2009-15 85 Table 35: Alogliptin/ACTOS combo: sales forecast ($m), 2009-15 85 Table 36: Enbrel: overview 88 Table 37: Enbrel: sales forecast ($m), 2009-15 89 Table 38: Amitiza: overview 91 Table 39: Amitiza: sales forecast ($m), 2009-15 92 Table 40: Exchange rates, 2010 95 TABLE OF FIGURES Figure 1: The PharmaVitae Explorer 3 Figure 2: Takeda prescription pharmaceutical performance, sales ($m) and growth rate (%), 2003-15 7 Figure 3: Takeda's financial performance ($m), 2003-15 8 Figure 4: Major expiry product sales ($m), 2009-15 10 Figure 5: Oncology investment drives long-term therapeutic strategy 12 Figure 6: Lifecycle management of gastroenterology portfolio, sales ($m), 2009-15 13 Figure 7: Lifecycle management of antidiabetic portfolio, sales ($m), 2009-15 14 Figure 8: Takeda SWOT analysis 15 Full Table of Contents is available at: -- http://www.fastmr.com/ About Datamonitor The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment. View more research from Datamonitor at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|